SARS-CoV-2 Nucleic Acid Detection Kit Clinical Performance Study

Clinical trial NCT05492227 · COMPLETED

Trial details

NCT number: NCT05492227
Sponsor: TransGen Biotech Co., LTD
Status: COMPLETED
Study type: OBSERVATIONAL

COVID-19 Coronavirus Disease 2019 COVID-19 Pandemic Diagnoses Disease

Start date: 2022-07-05
Primary completion: 2022-09-30
Enrollment: 607

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.